This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 November,
Austria Center Vienna

The Industry’s Leading Event in Europe to Accelerate Therapeutics to Market by Expediting R&D, Improving CMC Efficiency, and Building New Partnerships

Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.

Call for Speakers Now Open – Seeking Speakers on These Topics

Key Themes to Be Covered at TIDES Europe 2022


Oligonucleotide Discovery, Preclinical and Clinical

Oligonucleotide CMC and Manufacturing

Peptide Discovery, Preclinical and Clinical

Peptide CMC and Manufacturing

mRNA Therapeutics and Vaccines: Discovery, Clinical, Analytical and CMC Strategies

Genome Editing, Base Editing, Prime Editing: Discovery to Clinic and CMC Strategies

Drug Delivery for Macromolecules (Oligos, Peptides, mRNA, Genome Editing)

Regulatory/Quality Perspectives on Oligos, Peptides, mRNA and Genome Editing

Formulations and Drug Product Development Strategies

Analytical Development Case Studies throughout the Product Development Lifecycle

KEY AREAS OF FOCUS

Cross-fertilize Ideas and Best Practices with Industry Experts Across Multiple Discipline Areas.

The TIDES Europe 2022 hybrid program features 3 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum and areas of focus below.

Oligonucleotide Chemistry, Manufacturing & Controls

Comprehensive CMC, analytical, manufacturing and regulatory strategies for both drug substance and drug product to accelerate oligonucleotide product development.

Oligonucleotide Discovery, Preclinical and Clinical

Design oligonucleotides with better drug-like properties to accelerate your products to the clinic and to market. The latest preclinical and clinical updates to benchmark your research and improve your clinical efforts.

Peptide Chemistry, Manufacturing & Controls

Improve process efficiencies and overcome challenges in process development, CMC and manufacturing. Understand regulatory expectations, new technologies and alternative approaches for emerging complex molecules.

Peptide Discovery, Preclinical and Clinical

Explore new frontiers in peptide synthesis, discovery, design and engineering to improve targeting, delivery and drug-like properties. Case studies on the latest preclinical and clinical successes of peptides and peptide-like scaffolds and structures.

mRNA Therapeutics and Genome Editing

Hear updates on discovery strategies, clinical progress and CMC approaches for mRNA therapeutics and vaccines from industry-leading companies

Macromolecular Drug Delivery

Learn about the latest technologies and approaches to overcome the delivery challenges of oligonucleotides, peptides, mRNA and other macromolecules and discover new delivery strategies for genome editing

CONNECT WITH THE INDUSTRY ANYWHERE IN THE WORLD

Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals. We have both physical or digital opportunities, so we can adjust to whatever you are looking for.

To begin building your custom sponsorship package today, contact:

(Companies A-I) Michael Dunnet | 857-504-6732 | MDunnet@informaconnectls.com

(Companies J-Z) Michael Moriarty | 646-895-7412 | MMoriarty@informaconnectls.com

TIDES US 2020 Virtual Attendee

"Overall, the virtual sessions were better than live sessions.  I could see who was attending, more questions were put forward in the virtual format vs approaching a microphone. The virtual format allowed viewing of past sessions making it easier to see everything and keep up with other critical work activities."